Using summary statistics derived instead from the GWAS study of IBD, UC, and CD, no effect was seen of MCP‐1 on IBD and UC, whereas for CD, increased levels of MCP‐1 were found to increase odds of disease. Here, CCL2 is linked to inflammatory bowel disease.